Doctors Challenge NICE Guidelines on Heart Drug

November 22, 2007 at 6:16 PM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
Doctors Challenge NICE Guidelines on Heart Drug
Doctors in this week’s BMJ argue that new NICE guidelines on the use of digoxin, a drug used to slow heart rate in patients with irregular heart rhythm (atrial fibrillation), are inconsistent with the evidence.

Atrial fibrillation occurs when the electrical signals which keep the heart pumping, become disturbed. It is the most common heart rhythm problem especially in elderly people.

In June 2006, the UK National Institute for Health and Clinical Excellence (NICE) published new guidelines for control of heart rate in people with chronic atrial fibrillation. The guidelines depart from historical practice by recommending that instead of digoxin, two other types of drug (beta-blockers or calcium antagonists) should be the preferred initial treatment.

US guidelines also recommend the use of beta-blockers or calcium antagonists alone to control heart rate.

But two doctors at the Royal Hallamshire Hospital in Sheffield warn that it is safest to start treatment with digoxin first.

They reviewed 57 studies, including 25 randomised controlled trials, assessing digoxin, beta-blockers, calcium antagonists, and combinations for heart rate control in chronic atrial fibrillation.

They found little evidence that single treatment (monotherapy) with beta-blockers or calcium antagonists improves exercise tolerance compared with digoxin. On the contrary, there is clear evidence that when beta-blockers are used alone, exercise capacity may worsen, especially in people with a history of heart failure.

Similarly, little evidence exists that monotherapy with these drugs improves heart rate control at rest and during exercise compared with digoxin alone. Benefits on heart rate variability, together with improved exercise tolerance, have only been shown with the combination of digoxin and a beta-blocker or calcium antagonist, they say.

“We believe that the combination of digoxin and a beta-blocker or calcium antagonist should be recommended as first line management and we would emphasise that it is safest to start treatment with digoxin first,” they conclude.

Source-BMJ
SRM/P

 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
Quiz on Heart
A quiz on heart to learn more about its functions.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Heart
Complete Medindia Resources
News Categories:  
Kidney Health Center

Drug Related News

» Revision in Quality Standards for Heparin » Acne Drug Users At High Risk of Developing Eye Infections
» Patients Who Take Antidepressants When in ICU More Likely to Die » New Tablet Coating Product by Ideal Cures, In Geneva
» Prednisolone Benefits Patients With Bell's Palsy » 'Orphan' Sleep Drug may Fight Cancer
» New Drugs for Fox Tapeworm Infection » Poor Quality Antimalarial Drugs Pose Threat
Read More >>